REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients

Launch of the REVERT project clinical study: research and innovation to support colorectal cancer patients

The REVERT (taRgeted thErapy for adVanced colorEctal canceR paTients) project, financedby the European Horizon 2020 Programme and led by the…

06/22/2023

The Regional Institute of Oncology – Iasi, Romania, partner of the REVERT project, is looking for: a Colorectal surgeon a…

06/21/2023

PROJECT DESCRIPTION The Regional Institute of Oncology – Iasi, Romania, is looking for a Colorectal surgeon within the REVERT team.…

06/20/2023

PROJECT DESCRIPTION The Regional Institute of Oncology – Iasi, Romania, is looking for a PhD Researcher within the REVERT team.…

06/20/2023

REVERT Project promoted on FAIR: “GET CLOSER TO EUROPE IN THE REGION OF MURCIA” As every year, the “Europe Day”…

06/08/2023

In February 09-10 2023 the REVERT partners met in Cartagena and Murcia todiscuss about the activities carried out since the beginning of the…

02/20/2023

In November 28-29 2022 the REVERT partners met in Rome in the San Raffaele Research Center headquarters, leader of the…

12/21/2022

Revert was promoted in the latest issue of the HiPEACH network newsletter (European Network of Excellence on High Performance and…

10/19/2022

September will be dedicated to the EuropaColon Italy “The best of Tomorrow” campaign, in support of people with metastatic colorectal…

09/13/2022

The study provides an overview of how Artificial Intelligence (AI) can positively impact future healthcare, increasing the efficiency of clinicians,…

08/23/2022

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 848098”.